ENGLEWOOD HOSPITAL & MED CTR — History
CCN 310045 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$967M
Latest Revenue (FY2022)
+15.9%
Revenue CAGR (3yr)
0.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $720M | $875M | $967M | +10.5% | +15.9% |
| Operating Expenses | $782M | $883M | $967M | +9.5% | +11.2% |
| Operating Margin | -8.6% | -0.8% | 0.1% | +108.6% | +0.0% |
| Net Income | $-62M | $-7M | $1M | +109.5% | +0.0% |
| Licensed Beds | 284 | 274 | 292 | +6.6% | +1.4% |
| Total Patient Days | 69,483 | 68,791 | 69,538 | +1.1% | +0.0% |
| Medicare Day % | 34% | 32% | 32% | -0.6% | -2.9% |
| Medicaid Day % | 6% | 5% | 6% | +17.4% | +1.6% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +34.3% ($720M → $967M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+15.9%
This Hospital
+7.6%
State Avg
Latest Margin
0.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.1B | 4.4% |
| FY2024 (proj) | $1.2B | 8.7% |
| FY2025 (proj) | $1.3B | 13.0% |